Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Ottawa Marriott Hotel

Oct 18, 2016 8:00 AM - Oct 19, 2016 4:00 PM

100 Kent Street , Ottawa, ON K1P5R7 , CANADA

DIA Annual Canadian Meeting 2016

Explore how innovation can support new initiatives, regulatory processes, research, transparency, engagement, personalized medicine, and use of real-world data in Canada.


Short Courses*: October 17
Meeting: October 18-19 
Short Course 1: Plain Language Labeling: Implementing Health Canada’s Guidance for Industry
Short Course 2: Innovation in Rx-to-OTC Switch

*Short Courses require registration and an additional fee.

Innovation to support collaboration, engagement, and openness across the Canadian health care landscape

There has been an increased call and focus on innovation and collaboration across the health product development and regulatory system in Canada. The 2016-17 Budget announced by the Government of Canada placed an important emphasis on developing Canada’s culture of innovation. Health Canada continues to support this effort with their strategic plans and priorities, new and ongoing openness and transparency initiatives, and opportunities for engagement and collaboration with industry, patients, provinces and territories, and many other stakeholder groups.

What does innovation mean to you? The DIA Annual Canadian Meeting 2016 will bring together key thought leaders, industry experts, academics, medical professionals, and Health Canada representatives, to explore how innovation can drive and support new initiatives, regulatory processes, research, transparency, engagement, personalized medicine, use of real-world data, and much more!

This year’s meeting will feature plenary sessions, multi-track breakout sessions, networking opportunities, short courses, round table lunch discussions, and tabletop exhibiting opportunities. There will be sessions tailored to the beginner, intermediate, and advanced level professional.

Network early and start engaging on social media using the hashtag #DIACanada2016.

Community Outreach Event

Join us in giving back to the community!  This year, we are partnering with the Children’s Hospital of Eastern Ontario (CHEO) to kick off the DIA Annual Canadian Meeting 2016 with a community outreach activity!

For more information visit the Registration page.


Want to learn more about DIA Annual Canadian Meeting 2016? You've come to the right site!



Who should attend?

Professionals involved in:

  • Regulatory Affairs
  • Policy
  • Pharmacoeconomics
  • Clinical Development
  • Medical Affairs
  • Drug Safety/Pharmacovigilance
  • Patient Safety
  • Medical Communications
  • Quality Operations

Learning objectives

At the conclusion of this meeting, participants should be able to:

  • Describe the current and evolving regulatory environment in Canada
  • Analyze the current innovations in Canada’s health care and medical product development landscapes
    • Summarize methods and approaches to instill innovation in various aspects of clinical trials, patient engagement, supply chain, and manufacturing
  • Discuss the compliance, medical, legal, and regulatory considerations for social media use in the medical product development process
  • Review and examine the various levels of transparency that have been introduced into Canada’s health care landscape

Short Course or Primer

To keep you at the forefront.

Oct 17, 2016

Course 1:

Plain Language Labeling

Oct 17, 2016

Course 2:

Innovation in Rx-to-OTC Switch

Program Committee

  • Marilena  Bassi, MA
    Marilena Bassi, MA Senior Executive Director, Therapeutic Products Directorate
    Health Canada, Canada
  • Deirdre  Cozier
    Deirdre Cozier Director, Global Regulatory Affairs
    Pharmascience, Canada
  • Loretta  Del Bosco
    Loretta Del Bosco Director, Regulatory Affairs Quality Assurance Operations
    AbbVie Corporation, Canada
  • Laura  Durno, MS, MSc
    Laura Durno, MS, MSc Acting Chief, Viral Vaccines Division
    Biologics and Genetic Therapies Directorate, Health Canada, Canada
  • Karen  Feltmate
    Karen Feltmate President
    Redstone Health Group, Inc., Canada
  • Maggie  Graham
    Maggie Graham Senior Policy Analyst, Natural and Non-Prescription Health Products Directorate
    Health Canada, Canada
  • Vratislav  Hadrava, MD, PhD
    Vratislav Hadrava, MD, PhD Vice President and Medical Director, Global Innovative Products
    Pfizer Canada, Inc., Canada
  • Keith  McIntosh
    Keith McIntosh Executive Director, Scientific & Regulatory Affairs
    Innovative Medicines Canada, Canada
  • Marc  Poitras, PhD, MBA
    Marc Poitras, PhD, MBA Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau
    Health Canada, Canada
  • Matthew  Ryan
    Matthew Ryan Senior Policy Analyst; Policy, Planning and International Affairs Directorate
    Health Canada, Canada

Digital Learning Catalog

DIA Learning: eLearning Soultions

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.